| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.91 | 0.003 | 0.91 | Antiadrenergic | 0.893 0.004 CID_129632 | ||
| 0.909 | 0.003 | 0.909 | Adrenaline antagonist | 0.892 0.004 CID_129632 | ||
| 0.838 | 0.003 | 0.848 | Vasodilator, peripheral | 0.848 0.003 CID_129632 | CID_129632 | |
| 0.803 | 0.004 | 0.803 | Cardiotonic | 0.778 0.004 CID_129632 | ||
| 0.693 | 0.005 | 0.721 | Vasodilator, coronary | 0.721 0.004 CID_129632 | CID_129632 | |
| 0.657 | 0.002 | 0.753 | Beta adrenoreceptor antagonist | 0.753 0.001 CID_129632 | CID_129632 | |
| 0.616 | 0.011 | 0.64 | Spasmolytic | 0.64 0.01 CID_129632 | CID_129632 | |
| 0.57 | 0.007 | 0.577 | Vasodilator | 0.577 0.007 CID_129632 | CID_129632 | |
| 0.567 | 0.034 | 0.569 | Cyclophilin D inhibitor | 0.569 0.033 CID_129632 | CID_129632 | |
| 0.502 | 0.002 | 0.562 | Beta 1 adrenoreceptor antagonist | 0.562 0.002 CID_129632 | CID_129632 | |
| 0.516 | 0.034 | 0.516 | Antiobesity | 0.469 0.045 CID_129632 | ||
| 0.45 | 0.001 | 0.45 | Calcium-sensing receptor antagonist | 0.428 0.002 CID_129632 | ||
| 0.443 | 0.002 | 0.52 | Beta 2 adrenoreceptor antagonist | 0.52 0.002 CID_129632 | CID_129632 | |
| 0.433 | 0.005 | 0.433 | Anesthetic local | 0.383 0.007 CID_129632 | ||
| 0.418 | 0.005 | 0.42 | Insulin sensitizer | 0.42 0.005 CID_129632 | CID_129632 | |
| 0.403 | 0.016 | 0.407 | P-glycoprotein inhibitor | 0.407 0.015 CID_129632 | CID_129632 | |
| 0.377 | 0.002 | 0.433 | Beta 3 adrenoreceptor antagonist | 0.433 0.002 CID_129632 | CID_129632 | |
| 0.356 | 0.004 | 0.356 | Calcium antagonist | 0.288 0.005 CID_129632 | ||
| 0.353 | 0.003 | 0.411 | Adrenaline agonist | 0.411 0.003 CID_129632 | CID_129632 | |
| 0.372 | 0.028 | 0.389 | Sodium/bile acid cotransporter inhibitor | 0.389 0.02 CID_129632 | CID_129632 | |
| 0.342 | 0.017 | 0.342 | Ca(v)3.3 blocker | 0.318 0.029 CID_129632 | ||
| 0.38 | 0.086 | 0.392 | Histamine release inhibitor | 0.392 0.08 CID_129632 | CID_129632 | |
| 0.349 | 0.065 | 0.363 | Antithrombotic | 0.363 0.06 CID_129632 | CID_129632 | |
| 0.288 | 0.011 | 0.288 | Calcium channel blocker | 0.217 0.024 CID_129632 | ||
| 0.299 | 0.023 | 0.299 | Diuretic | 0.27 0.028 CID_129632 | ||
| 0.273 | 0.004 | 0.346 | Keratolytic | 0.346 0.004 CID_129632 | CID_129632 | |
| 0.336 | 0.071 | 0.364 | Cholesterol antagonist | 0.364 0.059 CID_129632 | CID_129632 | |
| 0.25 | 0.006 | 0.25 | Sphingosine 1-phosphate receptor 2 agonist | 0.219 0.009 CID_129632 | ||
| 0.248 | 0.01 | 0.248 | Nav1.6 sodium channel blocker | 0.235 0.011 CID_129632 | ||
| 0.239 | 0.003 | 0.239 | Sphingosine 1-phosphate receptor agonist | 0.16 0.004 CID_129632 | ||
| 0.235 | 0.003 | 0.235 | Sphingosine 1-phosphate receptor 1 agonist | 0.169 0.003 CID_129632 | ||
| 0.242 | 0.014 | 0.259 | Bronchodilator | 0.259 0.012 CID_129632 | CID_129632 | |
| 0.233 | 0.009 | 0.242 | Uric acid excretion stimulant | 0.242 0.008 CID_129632 | CID_129632 | |
| 0.243 | 0.023 | 0.243 | Nav1.2 sodium channel blocker | 0.185 0.04 CID_129632 | ||
| 0.243 | 0.024 | 0.243 | Interleukin 6 antagonist | 0.242 0.025 CID_129632 | ||
| 0.287 | 0.07 | 0.451 | Aldehyde oxidase inhibitor | 0.451 0.04 CID_129632 | CID_129632 | |
| 0.26 | 0.043 | 0.295 | DNA methyltransferase I inhibitor | 0.295 0.028 CID_129632 | CID_129632 | |
| 0.228 | 0.017 | 0.228 | Nav1.3 sodium channel blocker | 0.176 0.034 CID_129632 | ||
| 0.272 | 0.064 | 0.314 | Hypoglycemic | 0.314 0.048 CID_129632 | CID_129632 | |
| 0.229 | 0.024 | 0.229 | Insulin secretagoues | 0.229 0.024 CID_129632 | ||
| 0.31 | 0.109 | 0.315 | Immunosuppressant | 0.315 0.106 CID_129632 | CID_129632 | |
| 0.331 | 0.132 | 0.331 | 5 Hydroxytryptamine release inhibitor | 0.315 0.149 CID_129632 | ||
| 0.208 | 0.01 | 0.233 | Adenylate cyclase stimulant | 0.233 0.005 CID_129632 | CID_129632 | |
| 0.249 | 0.062 | 0.295 | Interleukin antagonist | 0.295 0.049 CID_129632 | CID_129632 | |
| 0.339 | 0.155 | 0.398 | Caspase 9 stimulant | 0.398 0.112 CID_129632 | CID_129632 | |
| 0.265 | 0.082 | 0.265 | 5 Hydroxytryptamine release stimulant | 0.234 0.097 CID_129632 | ||
| 0.25 | 0.068 | 0.297 | Tyrosine 3 hydroxylase inhibitor | 0.297 0.035 CID_129632 | CID_129632 | |
| 0.21 | 0.031 | 0.21 | Alpha-N-acetylglucosaminidase inhibitor | 0.176 0.042 CID_129632 | ||
| 0.173 | 0.005 | 0.173 | Sphingosine 1-phosphate receptor 4 agonist | 0.143 0.01 CID_129632 | ||
| 0.169 | 0.003 | 0.245 | Beta adrenoreceptor agonist | 0.245 0.002 CID_129632 | CID_129632 | |
| 0.222 | 0.057 | 0.246 | Nitric-oxide synthase stimulant | 0.246 0.035 CID_129632 | CID_129632 | |
| 0.172 | 0.008 | 0.172 | Calcium channel L-type blocker | 0.129 0.014 CID_129632 | ||
| 0.18 | 0.016 | 0.215 | Androgen antagonist | 0.215 0.012 CID_129632 | CID_129632 | |
| 0.17 | 0.01 | 0.17 | MAP kinase kinase 1 inhibitor | 0.153 0.015 CID_129632 | ||
| 0.254 | 0.097 | 0.312 | Hypoxia-inducible factor 1 alpha inhibitor | 0.312 0.06 CID_129632 | CID_129632 | |
| 0.221 | 0.066 | 0.252 | DNA methylase inhibitor | 0.252 0.047 CID_129632 | CID_129632 | |
| 0.225 | 0.071 | 0.241 | Peptidyltransferase inhibitor | 0.241 0.057 CID_129632 | CID_129632 | |
| 0.18 | 0.025 | 0.2 | Expectorant | 0.2 0.02 CID_129632 | CID_129632 | |
| 0.158 | 0.004 | 0.158 | Sphingosine 1-phosphate receptor 3 agonist | 0.143 0.004 CID_129632 | ||
| 0.193 | 0.043 | 0.206 | ATPase inhibitor | 0.206 0.032 CID_129632 | CID_129632 | |
| 0.163 | 0.026 | 0.172 | Mucolytic | 0.172 0.022 CID_129632 | CID_129632 | |
| 0.21 | 0.075 | 0.21 | MAP kinase kinase 2 inhibitor | 0.197 0.084 CID_129632 | ||
| 0.221 | 0.087 | 0.221 | Neuropeptide Y2 antagonist | 0.21 0.103 CID_129632 | ||
| 0.136 | 0.014 | 0.136 | Glutamate release inhibitor | 0.115 0.026 CID_129632 | ||
| 0.12 | 0.004 | 0.15 | Beta 2 adrenoreceptor agonist | 0.15 0.003 CID_129632 | CID_129632 | |
| 0.244 | 0.132 | 0.326 | Transcription factor NF kappa B inhibitor | 0.326 0.084 CID_129632 | CID_129632 | |
| 0.114 | 0.003 | 0.176 | Beta 1 adrenoreceptor agonist | 0.176 0.002 CID_129632 | CID_129632 | |
| 0.113 | 0.004 | 0.113 | Calcium channel P-type blocker | 0.09 0.009 CID_129632 | ||
| 0.199 | 0.094 | 0.22 | Cyclic AMP phosphodiesterase inhibitor | 0.22 0.08 CID_129632 | CID_129632 | |
| 0.139 | 0.038 | 0.139 | Nav1.1 sodium channel blocker | 0.129 0.043 CID_129632 | ||
| 0.193 | 0.097 | 0.193 | ErbB-1 antagonist | 0.189 0.102 CID_129632 | ||
| 0.137 | 0.041 | 0.137 | Calcium channel (voltage-sensitive) blocker | 0.098 0.087 CID_129632 | ||
| 0.12 | 0.026 | 0.122 | Ornithine decarboxylase inhibitor | 0.122 0.024 CID_129632 | CID_129632 | |
| 0.103 | 0.01 | 0.14 | Heat shock protein 90 beta antagonist | 0.14 0.005 CID_129632 | CID_129632 | |
| 0.096 | 0.009 | 0.096 | Sphingosine 1-phosphate receptor 5 agonist | 0.079 0.013 CID_129632 | ||
| 0.106 | 0.02 | 0.106 | Phosphodiesterase III inhibitor | 0.102 0.022 CID_129632 | ||
| 0.136 | 0.05 | 0.136 | Interleukin 1b antagonist | 0.111 0.07 CID_129632 | ||
| 0.208 | 0.124 | 0.218 | Transcription factor STAT3 inhibitor | 0.218 0.113 CID_129632 | CID_129632 | |
| 0.154 | 0.073 | 0.176 | Interferon gamma antagonist | 0.176 0.053 CID_129632 | CID_129632 | |
| 0.124 | 0.045 | 0.149 | AMP-activated protein kinase stimulant | 0.149 0.029 CID_129632 | CID_129632 | |
| 0.097 | 0.019 | 0.097 | Secretase beta inhibitor | 0.088 0.027 CID_129632 | ||
| 0.118 | 0.041 | 0.134 | Anabolic | 0.134 0.028 CID_129632 | CID_129632 | |
| 0.09 | 0.013 | 0.09 | Gonadotropin-releasing hormone receptor agonist | 0.09 0.013 CID_129632 | ||
| 0.1 | 0.024 | 0.114 | Estrogen-related receptor beta agonist | 0.114 0.013 CID_129632 | CID_129632 | |
| 0.118 | 0.044 | 0.118 | UDP-glucose 4-epimerase inhibitor | 0.111 0.05 CID_129632 | ||
| 0.076 | 0.003 | 0.106 | Beta 3 adrenoreceptor agonist | 0.106 0.003 CID_129632 | CID_129632 | |
| 0.159 | 0.089 | 0.18 | Phospholipase C inhibitor | 0.18 0.06 CID_129632 | CID_129632 | |
| 0.083 | 0.013 | 0.083 | Heme oxygenase stimulant | 0.083 0.013 CID_129632 | ||
| 0.153 | 0.085 | 0.153 | Growth hormone agonist | 0.153 0.085 CID_129632 | ||
| 0.193 | 0.127 | 0.196 | Interleukin agonist | 0.196 0.124 CID_129632 | CID_129632 | |
| 0.128 | 0.063 | 0.15 | Aldehyde dehydrogenase inhibitor | 0.15 0.048 CID_129632 | CID_129632 | |
| 0.145 | 0.081 | 0.313 | Peroxidase inhibitor | 0.313 0.035 CID_129632 | CID_129632 | |
| 0.129 | 0.073 | 0.167 | Interleukin 4 antagonist | 0.167 0.037 CID_129632 | CID_129632 | |
| 0.229 | 0.173 | 0.229 | Calcium channel activator | 0.214 0.192 CID_129632 | ||
| 0.073 | 0.017 | 0.073 | Sphingosine 1-phosphate receptor 1 antagonist | 0.066 0.021 CID_129632 | ||
| 0.201 | 0.147 | 0.201 | Gastrin inhibitor | |||
| 0.16 | 0.107 | 0.162 | Psychostimulant | 0.162 0.106 CID_129632 | CID_129632 | |
| 0.084 | 0.038 | 0.084 | Sphingosine 1-phosphate receptor antagonist | 0.078 0.049 CID_129632 | ||
| 0.102 | 0.057 | 0.102 | Sphingomyelinase inhibitor | |||
| 0.053 | 0.013 | 0.053 | Vascular adhesion protein 1 inhibitor | |||
| 0.117 | 0.077 | 0.117 | MAP kinase kinase inhibitor | 0.117 0.077 CID_129632 | ||
| 0.048 | 0.008 | 0.048 | Cholesterol ester transfer protein antagonist | 0.042 0.012 CID_129632 | ||
| 0.117 | 0.078 | 0.117 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.055 | 0.016 | 0.055 | HIV-1 protease inhibitor | 0.054 0.017 CID_129632 | ||
| 0.097 | 0.062 | 0.156 | Xanthine oxidase inhibitor | 0.156 0.032 CID_129632 | CID_129632 | |
| 0.164 | 0.129 | 0.24 | Antiamyloidogenic | 0.24 0.076 CID_129632 | CID_129632 | |
| 0.086 | 0.053 | 0.086 | Histamine H2 receptor antagonist | 0.076 0.074 CID_129632 | ||
| 0.041 | 0.008 | 0.041 | Follicle-stimulating hormone agonist | 0.029 0.01 CID_129632 | ||
| 0.078 | 0.045 | 0.078 | Vanilloid 4 agonist | |||
| 0.118 | 0.087 | 0.118 | Sodium channel blocker | |||
| 0.116 | 0.089 | 0.138 | Bone formation stimulant | 0.138 0.069 CID_129632 | CID_129632 | |
| 0.069 | 0.042 | 0.069 | Potassium channel (ATP-sensitive) blocker | |||
| 0.087 | 0.061 | 0.087 | NADH dehydrogenase inhibitor | 0.087 0.061 CID_129632 | ||
| 0.121 | 0.095 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | 0.117 0.105 CID_129632 | ||
| 0.059 | 0.034 | 0.059 | Cathepsin D inhibitor | 0.052 0.039 CID_129632 | ||
| 0.09 | 0.065 | 0.09 | Potassium channel (Ca-activated) activator | 0.086 0.068 CID_129632 | ||
| 0.093 | 0.071 | 0.093 | Protease inhibitor | |||
| 0.04 | 0.018 | 0.04 | Growth hormone releasing factor agonist | |||
| 0.073 | 0.053 | 0.073 | Potassium channel (Tandem pore domain) blocker | |||
| 0.059 | 0.039 | 0.059 | Sphingosine 1-phosphate receptor 3 antagonist | 0.053 0.051 CID_129632 | ||
| 0.095 | 0.076 | 0.111 | Mediator release inhibitor | 0.111 0.057 CID_129632 | CID_129632 | |
| 0.085 | 0.067 | 0.085 | Triose-phosphate isomerase inhibitor | |||
| 0.062 | 0.044 | 0.062 | Nitric oxide donor | 0.061 0.047 CID_129632 | ||
| 0.043 | 0.025 | 0.043 | Plasmepsin II inhibitor | |||
| 0.063 | 0.048 | 0.063 | Fibroblast growth factor 2 antagonist | 0.059 0.053 CID_129632 | ||
| 0.058 | 0.044 | 0.066 | Androgen agonist | 0.066 0.034 CID_129632 | CID_129632 | |
| 0.207 | 0.193 | 0.207 | Toll-Like receptor agonist | 0.202 0.199 CID_129632 | ||
| 0.065 | 0.052 | 0.09 | Phenylalanine 4-hydroxylase inhibitor | 0.09 0.031 CID_129632 | CID_129632 | |
| 0.125 | 0.112 | 0.125 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.059 | 0.046 | 0.059 | Adrenaline uptake inhibitor | |||
| 0.054 | 0.041 | 0.073 | Alcohol oxidase inhibitor | 0.073 0.027 CID_129632 | CID_129632 | |
| 0.13 | 0.118 | 0.172 | Nitric oxide antagonist | 0.172 0.08 CID_129632 | CID_129632 | |
| 0.05 | 0.038 | 0.05 | Aconitate hydratase inhibitor | |||
| 0.149 | 0.138 | 0.149 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.099 | 0.088 | 0.099 | Nav1.5 sodium channel blocker | |||
| 0.051 | 0.04 | 0.051 | Thromboxane antagonist | |||
| 0.145 | 0.135 | 0.145 | Anticonvulsant | |||
| 0.079 | 0.07 | 0.081 | D-Ala-D-Ala ligase inhibitor | 0.081 0.066 CID_129632 | CID_129632 | |
| 0.051 | 0.042 | 0.051 | Alpha-mannosidase inhibitor | |||
| 0.127 | 0.119 | 0.159 | Melanin inhibitor | 0.159 0.071 CID_129632 | CID_129632 | |
| 0.064 | 0.057 | 0.103 | Histidine decarboxylase inhibitor | 0.103 0.031 CID_129632 | CID_129632 | |
| 0.029 | 0.022 | 0.029 | Plasmepsin I inhibitor | |||
| 0.204 | 0.196 | 0.204 | Toll-Like receptor 7 agonist | |||
| 0.046 | 0.039 | 0.046 | Thromboxane A2 antagonist | |||
| 0.026 | 0.019 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.016 CID_129632 | CID_129632 | |
| 0.079 | 0.072 | 0.081 | Transcription factor NF kappa B stimulant | 0.081 0.068 CID_129632 | CID_129632 | |
| 0.079 | 0.073 | 0.079 | Alpha adrenoreceptor antagonist | |||
| 0.016 | 0.012 | 0.016 | Vitamin D receptor agonist | 0.015 0.014 CID_129632 | ||
| 0.024 | 0.021 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.018 CID_129632 | CID_129632 | |
| 0.018 | 0.015 | 0.018 | Growth hormone release promoting | |||
| 0.106 | 0.102 | 0.106 | Sodium channel (voltage-gated) blocker | |||
| 0.064 | 0.061 | 0.064 | Aminopeptidase I inhibitor | |||
| 0.092 | 0.09 | 0.092 | Factor V inhibitor | |||
| 0.138 | 0.137 | 0.138 | Succinate dehydrogenase inhibitor | |||
| 0.063 | 0.064 | 0.089 | Glutamate decarboxylase inhibitor | 0.089 0.037 CID_129632 | CID_129632 | |
| 0.101 | 0.103 | 0.143 | Toll-Like receptor 2 antagonist | 0.143 0.058 CID_129632 | CID_129632 | |
| 0.162 | 0.167 | 0.187 | Superoxide dismutase inhibitor | 0.187 0.132 CID_129632 | CID_129632 | |
| 0.088 | 0.095 | 0.102 | Toll-Like receptor 4 antagonist | 0.102 0.066 CID_129632 | CID_129632 | |
| 0.075 | 0.089 | 0.092 | Alcohol dehydrogenase inhibitor | 0.092 0.062 CID_129632 | CID_129632 | |
| 0.059 | 0.076 | 0.096 | Topoisomerase II alpha inhibitor | 0.096 0.042 CID_129632 | CID_129632 | |
| 0.145 | 0.164 | 0.172 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.172 0.105 CID_129632 | CID_129632 | |
| 0.039 | 0.06 | 0.059 | Xanthine dehydrogenase inhibitor | 0.059 0.039 CID_129632 | CID_129632 | |
| 0.044 | 0.066 | 0.058 | Neuraminidase inhibitor | 0.058 0.046 CID_129632 | CID_129632 | |
| 0.104 | 0.135 | 0.116 | Vanilloid 1 agonist | 0.116 0.099 CID_129632 | CID_129632 | |
| 0.12 | 0.152 | 0.132 | MAP kinase kinase 4 inhibitor | 0.132 0.107 CID_129632 | CID_129632 | |
| 0.023 | 0.062 | 0.033 | Estrogen-related receptor beta antagonist | 0.033 0.021 CID_129632 | CID_129632 | |
| 0.082 | 0.123 | 0.111 | DOPA decarboxylase inhibitor | 0.111 0.056 CID_129632 | CID_129632 | |
| 0.113 | 0.164 | 0.135 | CF transmembrane conductance regulator agonist | 0.135 0.107 CID_129632 | CID_129632 | |
| 0.075 | 0.13 | 0.129 | Amylase inhibitor | 0.129 0.075 CID_129632 | CID_129632 | |
| 0.033 | 0.092 | 0.064 | Purinergic P2X2 antagonist | 0.064 0.049 CID_129632 | CID_129632 | |
| 0.123 | 0.183 | 0.161 | Immunostimulant | 0.161 0.145 CID_129632 | CID_129632 | |
| 0.119 | 0.211 | 0.233 | Antioxidant | 0.233 0.094 CID_129632 | CID_129632 | |
| 0.059 | 0.201 | 0.131 | Lipid peroxidase inhibitor | 0.131 0.083 CID_129632 | CID_129632 | |
| 0.089 | 0.251 | 0.202 | Free radical scavenger | 0.202 0.096 CID_129632 | CID_129632 | |
| 0.044 | 0.33 | 0.11 | Estrogen antagonist | 0.11 0.075 CID_129632 | CID_129632 | |
| 0.033 | 0.332 | 0.098 | Estrogen receptor beta antagonist | 0.098 0.068 CID_129632 | CID_129632 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |